πŸ‡ΊπŸ‡Έ FDA
Patent

US 9718814

Cyclopropanamine compound and use thereof

granted A61PA61P25/00A61P25/08

Quick answer

US patent 9718814 (Cyclopropanamine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P25/00, A61P25/08, A61P25/14, A61P25/16